These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1042 related items for PubMed ID: 17288694

  • 1. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [Abstract] [Full Text] [Related]

  • 2. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 3. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
    Clin Drug Investig; 2007 Jun; 27(7):481-92. PubMed ID: 17563128
    [Abstract] [Full Text] [Related]

  • 4. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
    Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M.
    J Sex Med; 2007 Jul; 4(4 Pt 1):917-29. PubMed ID: 17627739
    [Abstract] [Full Text] [Related]

  • 5. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF.
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [Abstract] [Full Text] [Related]

  • 6. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
    Mallinckrodt CH, Prakash A, Andorn AC, Watkin JG, Wohlreich MM.
    J Psychiatr Res; 2006 Jun; 40(4):337-48. PubMed ID: 16271726
    [Abstract] [Full Text] [Related]

  • 7. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW, Lönn SL, Despiégel N.
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [Abstract] [Full Text] [Related]

  • 8. Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.
    Hirschfeld RM, Vornik LA.
    J Clin Psychiatry; 2004 Jul; 65 Suppl 4():46-52. PubMed ID: 15046541
    [Abstract] [Full Text] [Related]

  • 9. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
    Bielski RJ, Ventura D, Chang CC.
    J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
    [Abstract] [Full Text] [Related]

  • 10. Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
    Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M.
    Neuropsychobiology; 2007 Sep; 56(2-3):73-85. PubMed ID: 18037817
    [Abstract] [Full Text] [Related]

  • 11. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 12. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ.
    Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153
    [Abstract] [Full Text] [Related]

  • 13. Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.
    Wohlreich MM, Mallinckrodt CH, Watkin JG, Wilson MG, Greist JH, Delgado PL, Fava M.
    Ann Clin Psychiatry; 2005 Sep; 17(4):259-68. PubMed ID: 16402760
    [Abstract] [Full Text] [Related]

  • 14. Early symptom change prediction of remission in depression treatment.
    Katz MM, Meyers AL, Prakash A, Gaynor PJ, Houston JP.
    Psychopharmacol Bull; 2009 Sep; 42(1):94-107. PubMed ID: 19204654
    [Abstract] [Full Text] [Related]

  • 15. An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
    Wohlreich MM, Martinez JM, Mallinckrodt CH, Prakash A, Watkin JG, Fava M.
    J Clin Psychopharmacol; 2005 Dec; 25(6):552-60. PubMed ID: 16282837
    [Abstract] [Full Text] [Related]

  • 16. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
    Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA.
    J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
    [Abstract] [Full Text] [Related]

  • 17. Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.
    Bose A, Tsai J, Li D.
    Clin Drug Investig; 2012 Jun 01; 32(6):373-85. PubMed ID: 22559255
    [Abstract] [Full Text] [Related]

  • 18. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
    Emslie GJ, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS.
    J Child Adolesc Psychopharmacol; 2014 May 01; 24(4):170-9. PubMed ID: 24815533
    [Abstract] [Full Text] [Related]

  • 19. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
    Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA.
    J Clin Psychiatry; 2002 Apr 01; 63(4):308-15. PubMed ID: 12000204
    [Abstract] [Full Text] [Related]

  • 20. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
    Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M.
    Curr Med Res Opin; 2007 Feb 01; 23(2):245-50. PubMed ID: 17288677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.